ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,197,000 | -35.3% | 103,922 | -7.9% | 0.00% | -25.0% |
| Q2 2015 | $6,491,000 | -11.8% | 112,805 | -2.4% | 0.00% | -20.0% |
| Q1 2015 | $7,357,000 | +3.8% | 115,549 | +0.6% | 0.01% | 0.0% |
| Q4 2014 | $7,088,000 | +132.4% | 114,803 | +46.3% | 0.01% | +150.0% |
| Q3 2014 | $3,050,000 | -13.0% | 78,472 | -22.8% | 0.00% | 0.0% |
| Q2 2014 | $3,504,000 | -69.1% | 101,654 | -61.2% | 0.00% | -75.0% |
| Q1 2014 | $11,332,000 | +8.7% | 262,317 | +0.2% | 0.01% | 0.0% |
| Q4 2013 | $10,427,000 | +5.4% | 261,717 | -0.7% | 0.01% | -11.1% |
| Q3 2013 | $9,895,000 | +40.0% | 263,563 | +0.2% | 0.01% | +28.6% |
| Q2 2013 | $7,068,000 | – | 263,021 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
| WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
| DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
| HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
| Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
| PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
| Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
| Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
| PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |